Mobile Menu - OpenMobile Menu - Closed

Hearing on “Formula Safety and Supply: Protecting the Health of America’s Babies”

Date: 
Wednesday, May 25, 2022 - 11:00am
Location: 
Hybrid Hearing in the John D. Dingell Room, 2123 of the Rayburn House Office Building, and Cisco Webex

The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Wednesday, May 25, 2022, at 11:00 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco WebEx online video conferencing. The hearing is entitled, "Formula Safety and Supply: Protecting the Health of America’s Babies."

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Oversight and Investigations

Opening Statement from Chairman Pallone as prepared for delivery

Opening Statement from Subcommittee Chair DeGette as prepared for delivery

 

Livestream

 

Witnesses

Panel I

Hon. Robert M. Califf, M.D.
Commissioner
Food and Drug Administration

 

Frank Yiannas, M.P.H.
Deputy Commissioner
Food Policy and Response
Food and Drug Administration

 

Susan Mayne, Ph.D.
Director
Center for Food Safety and Applied Nutrition
Food and Drug Administration

 

Testimony of the Food and Drug Administration

 

Panel II

Christopher J. Calamari
President, U.S. and Canada Nutrition
Senior Vice President
Abbott

Testimony

 

Scott Fitz
Vice President
Technical and Production
Gerber Products Company

Testimony

 

Robert Cleveland
Senior Vice President
Nutrition, North America and Europe
Reckitt

Testimony

 

Issues: